Cytogenetics and molecular genetics of human solid tumours

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Cancer is fundamentally a genetic disease driven by accumulating genomic rearrangements.
• These rearrangements include chromosomal abnormalities and mutations in oncogenes and tumor suppressor genes.
• Tumor-specific translocations can lead to the formation of fusion genes, particularly in sarcomas.

Purpose of the Study:

• To review the specificity and implications of various genetic alterations in human solid tumors.
• To discuss genetic changes in both sporadic and hereditary cancers.
• To highlight the potential of these genetic alterations as tumor-specific markers.

Main Methods:

• Review of recent scientific literature on genetic alterations in human solid tumors.
• Analysis of specific translocation events and their resulting fusion genes.
• Examination of diagnostic and prognostic applications of genetic markers.

Main Results:

• Genetic alterations, including chromosomal translocations and gene mutations, are hallmarks of cancer development.
• Fusion genes resulting from translocations are observed in specific tumor types, such as sarcomas.
• These genetic changes offer potential as specific markers for cancer diagnosis and prognosis.

Conclusions:

• Genetic alterations are key drivers of cancer, offering insights into tumorigenesis.
• Understanding these alterations is crucial for developing targeted therapies and improving patient outcomes.
• Genetic markers hold significant promise for enhancing cancer diagnosis and prognosis.